Skip to main content
Close
Publicación

Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study).

Ver todas las publicaciones

Background: Strong and broad antiviral T-cell responses targeting vulnerable sites of HIV-1 will likely be a critical component for any effective cure strategy.

Methods: T-cells associated HIV-1 DNA. (NCT01712425).

Not available in
This is not available in . You can go to the translated versions in these languages: